1 Matching Annotations
- Sep 2018
Furthermore, drugs targeting the gut-liver axis (e.g. intregrin blockers such as vedolizumab, antibiotics) appear promising, based on the close link of PSC to inflammatory bowel disease and the emerging relevance of the gut microbiome for the development of PSC.
This doesn't mention Vancomycin. Is Vanco an integrin blocker?